---
title: "Why Is Canada-Based Cannabis Firm Canopy Growth Stock Trading Lower On Friday?"
date: "2025-02-07 23:05:27"
summary: "Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year."
categories:
  - "benzinga"
lang:
  - "en"
translations:
  - "en"
tags:
  - "benzinga"
menu: ""
thumbnail: "https://www.benzinga.com/files/images/story/2025/02/07/Viersen--Germany---January-9--2021-Close.jpeg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

[benzinga](https://www.benzinga.com/general/health-care/25/02/43562398/why-is-canada-based-cannabis-firm-canopy-growth-stock-trading-lower-on-friday)
